(2R)-(-)-GLYCIDYL TOSYLATE

(2R)-(-)-GLYCIDYL TOSYLATE

(R)-(-)-Glycidyl p-toluenesulfonate; (R)-(-)-Oxirane-2-methanol p-toluenesulfonate; ((2R)-Oxiran-2-yl)methyl 4-methylbenzenesulfonate; (-)-Glycidyl tosylate; (R)-Glycidyl tosylate; (R)-Oxiranemethanol 4-methylbenzenesulfonate;

PRODUCT IDENTIFICATION
CAS RN	113826-06-5
EINECS RN
FORMULA	C₁₀H₁₂O₄S
MASS	228.27

PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL STATE	white crystalline powder
MELTING POINT	46 - 48 C
BOILING POINT
DENSITY
SOLUBILITY IN WATER	Decomposes
pH
VAPOR DENSITY
REFRACTIVE INDEX
FLASH POINT	110 C

STABILITY AND REACTIVITY
STABILITY	Stable at room temperature in closed containers under normal storage and handling conditions. May decompose on exposure to moist air or water
INCOMPATIBLE MATERIALS	moisture, excess heat, strong oxidants
DECOMPOSITION PRODUCTS	Carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide
POLYMERIZATION	Has not been reported

SAFETY
HAZARD NOTES	Irritating to eyes, respiratory system and skin. Moisture sensitive
EYE	Causes eye irritation. May cause chemical conjunctivitis
SKIN	Cause skin irritation. Causes redness and pain
INGESTION	May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
INHALATION	Causes respiratory tract irritation. Can produce delayed pulmonary edema
CHRONIC	Effects may be delayed
UN NO.	3077
HAZARD CLASS	T N
PACKING GROUP	III
NFPA RATINGS
HAZARD SYMBOL
RISK PHRASES	45-41-43-51/53-68
SAFETY PHRASES	53-45-61

REFERENCES

Chiral Epoxides

Product	CAS RN.
(-)-Epoxycaryophyllene	1139-30-6
(+)-Limonene oxide	1195-92-2
(2S,3S)-(-)-3-(4-Nitrophenyl)glycidol	1885-07-0
(2R)-2-Ethyloxirane	3760-95-0
(2S,3S)-(-)-2-Methyl-3-phenyloxirane	4518-66-5
(2R,3R)-(+)-2-Methyl-3-phenyloxirane	14212-54-5
(-)-Benzyl (R)-glycidyl ether	14618-80-5
(R)-(+)-Propylene oxide	15448-47-2
(S)-(-)-Propylene oxide	16088-62-3
(+)-Benzyl (S)-glycidyl ether	16495-13-9
(S)-Styrene oxide	20780-54-5
(R)-Styrene oxide	20780-53-4
(2S)-Ethyloxirane	30608-62-9
(S)-(-)-1,2-Epoxyoctane	50418-68-3
(R)-(-)-Epichlorohydrin	51594-55-9
(R)-(+)-Glycidol	57044-25-4
(R)-(+)-1,2-Epoxytridecane	59829-81-1
(R)-(-)-Glycidyl butyrate	60456-26-0
(S)-(-)-Glycidol	60456-23-7
(2S)-2-(2-Bromoethyl)oxirane	61847-07-2
(S)-2-Vinyloxirane	62249-80-3
(R)-2-Vinyloxirane	62249-81-4
(R)-(+)-3-Chlorostyrene oxide	62600-71-9
(2S)-2-(Methoxymethyl)oxirane	64491-68-5
(2R)-2-(Methoxymethyl)oxirane	64491-70-9
(S)-(+)-Glycidyl butyrate	65031-96-1
(R)-(+)-Glycidyl trityl ether	65291-30-7
(S)-(+)-Epichlorohydrin	67843-74-7
(2S)-(+)-Glycidyl tosylate	70987-78-9
(S)-2-Oxiranylanisole	71031-03-3
Diethyl (2R,3R)-oxirane-2,3-dicarboxylate	74243-85-9
(R)-(+)-1,2-Epoxyoctane	77495-66-0
(S)-4-Nitrostyrene oxide	78038-42-3
(R)-4-Nitrostyrene oxide	78038-43-4
(R)-(+)-1,2-Epoxypentadecane	96938-06-6
(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane	98737-29-2
(2S,3S)-3-Phenylglycidol	104196-23-8
(R)-2-Butyloxirane	104898-06-8
(R)-(-)-Glycidyl 4-nitrobenzoate	106268-95-5
(2R)-(-)-2-Methylglycidyl 4-nitrobenzoate	106268-96-6
(2S,3S)-trans-3-Methyloxirane-2-methyl 4-nitrobenzoate	106268-97-7
(R)-(+)-1,2-Epoxydodecane	109856-85-1
(R)-2-Pentyloxirane	110549-07-0
Methyl (2R)-oxirane-2-carboxylate	111058-32-3
Ethyl (S)-3,4-epoxybutyrate	112083-63-3
(2R)-(-)-Glycidyl tosylate	113826-06-5
(S)-(+)-Glycidyl 3-nitrobenzenesulfonate	115314-14-2
(R)-(-)-Glycidyl 3-nitrobenzenesulfonate	115314-17-5
(S)-(+)-Glycidyl 4-nitrobenzoate	115459-65-9
(R)-(+)-1,2-Epoxytetradecane	116619-64-8
(2S)-(+)-2-Methylglycidyl 4-nitrobenzoate	118200-96-7
Methyl (2S)-oxirane-2-carboxylate	118712-39-3
tert-Butyldimethylsilyl (S)-(+)-glycidyl ether	123237-62-7
tert-Butyldimethylsilyl (R)-(–)-glycidyl ether	124150-87-4
(S)-(-)-Glycidyl trityl ether	129940-50-7
(2S)-2-(Trifluoromethyl)oxirane	130025-34-2
(S)-4-Fluorostyrene oxide	134356-74-4
(R)-4-Fluorostyrene oxide	134356-73-3
(2R)-2-Oct-7-enyloxirane	137310-67-9
(2R)-(+)-3,3-Dimethylglycidyl 4-nitrobenzoate	141700-91-6
(2R)-2-(Trifluoromethyl)oxirane	143142-90-9
(R,R)-(+)-1,2,9,10-Diepoxydecane	144741-95-7
(S)-N-Boc-2,3-epoxypropylamine	161513-47-9
(S)-N-Glycidylphthalimide	161596-47-0
(R)-N-Glycidylphthalimide	181140-34-1
(+)-Limonene 1,2-epoxide	203719-54-4
(2'R,3'R)-4'-Bromo-cis-2',3'-epoxybutyl (1S)-10-camphorsulfonate	308796-34-1
(2'S,3'S)-4'-Bromo-cis-2',3'-epoxybutyl (1S)-10-camphorsulfonate	343338-27-2
(2S)-2-(2-Chloroethyl)oxirane	948594-94-3

SALES SPECIFICATION
APPEARANCE	white crystalline powder
CHEMICAL PURITY	99.0% min
OPTICAL PURITY	99.0% min
SPECIFIC ROTATION	-17° ~ -19° (c=2.5, CHCl₃)
WATER	0.5% max